Patient Interviews to investigate psychosocial disease burden in patients with Psoriasis vulgaris in Japan

Patient Interviews to investigate psychosocial disease burden in patients with Psoriasis vulgaris in Japan - Patient Interviews to investigate psychosocial disease burden in patients with Psoriasis vulgaris in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051977

Enrollment

Registered

2023-08-22

Start date

2023-07-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis vulgaris

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Received a diagnosis of mild-to-severe psoriasis vulgaris -Has or had (within the last 3 years) skin eruptions due to psoriasis affecting any visible site (e.g. head, face, hands, lower legs) -18+ years of age at the time of screening -Currently receiving any treatment (including topical, oral, injectable, and phototherapy agents) -Capable of submitting written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Unable to attend or understand and respond to the questions posed during an audio-recorded interview conducted using one of the following formats: online video, in-person, or phone call (online or landline).

Design outcomes

Primary

Measure	Time frame
In this qualitative study, the primary endpoints broadly include the description of the concepts of highest relevance experienced by PsO patients related to the psychosocial burden of disease and how it has impacted their daily lives, social relationships, and life course decisions.	—

Countries

Japan

Contacts

Public ContactMiyu Okamura

Syneos Health Clinical K.K. Real World Evidence

miyu.okamura@syneoshealth.com03-3516-8601

Outcome results